Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 8/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1357871 | 1.00 | ACE (0.58) | ACEAPEX1CYP2C19PPARGPPARA | |
| SCHEMBL10268771 | 1.00 | ACE (0.58) | ACEAPEX1CYP2C19PPARGPPARA | |
| SCHEMBL11427580 | 0.85 | ACE (0.47) | ACEAPEX1CYP2C19PPARGPPARA | |
| SCHEMBL7011163 | 0.84 | ACE (0.61) | ACEAPEX1CYP2C19PPARGPPARA | |
| SCHEMBL3188945 | 0.82 | APEX1 (0.47) | ACEAPEX1PPARGPPARA | |
| SCHEMBL3188959 | 0.82 | APEX1 (0.47) | ACEAPEX1PPARGPPARA | |
| SCHEMBL5520904 | 0.82 | ACE (0.52) | ACECYP2C19PPARGPPARAMETAP2 | |
| SCHEMBL8914991 | 0.82 | ACE (0.63) | ACEAPEX1PPARGPPARA | |
| SCHEMBL5418068 | 0.81 | CYP1A2 (0.55) | ACECYP2C19PPARGPPARA | |
| SCHEMBL9226840 | 0.80 | ACE (0.50) | ACECYP2C19PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4224457-A | Process for manufacturing optically active sulfur-containing carboxylic acid | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1980-09-23 | — | — | US | claimed |
| EP-2389360-A2 | A PROCESS FOR THE PREPARATION OF ZOFENOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Glenmark Generics Limited (IN) | 2011-11-30 | — | — | EP | disclosed |
| US-20110253651-A1 | Drying rack with wrap-around cover | BEHJAT MOHAMMAD KAZEM | 2011-10-20 | — | — | US | disclosed |
| WO-2010084515-A2 | A PROCESS FOR THE PREPARATION OF ZOFENOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | GLENMARK GENERICS LIMITED (IN) | 2010-07-29 | — | — | WO | disclosed |
| EP-0932598-A1 | ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME | WARNER-LAMBERT COMPANY (US) | 1999-08-04 | — | — | EP | disclosed |
| WO-1998016502-A1 | ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME | WARNER-LAMBERT COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |
| US-5648524-A | SULFIDING | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1997-07-15 | — | — | US | disclosed |
| US-4411836-A | HEATING IN PRESENCE OF FATTY OR AROMATIC ACID SALT OR TERTIARY AMINE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-10-25 | — | — | US | disclosed |
| US-4297282-A | REACTING AN A-METHYL-B-ACYLTHIOPROPIONIC ACID WITH AN OPTICALLY ACTIVE ARYLALKYL PRIMARY AMINE; CRYSTALLIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-10-27 | — | — | US | disclosed |
| US-4224457-A | Process for manufacturing optically active sulfur-containing carboxylic acid | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1980-09-23 | — | — | US | disclosed |
| US-4154840-A | Antihypertensive pipecolic acid derivatives | E. R. SQUIBB & SONS, INC. (US) | 1979-05-15 | — | — | US | disclosed |
| US-4105776-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS, HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1978-08-08 | — | — | US | disclosed |